GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » Additional Paid-In Capital

Pharmocann Global (XTAE:PMCN-M) Additional Paid-In Capital : ₪86.24 Mil(As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global Additional Paid-In Capital?


Pharmocann Global's quarterly additional paid-in capital increased from Dec. 2022 (₪77.49 Mil) to Jun. 2023 (₪80.03 Mil) and increased from Jun. 2023 (₪80.03 Mil) to Dec. 2023 (₪86.24 Mil).

Pharmocann Global's annual additional paid-in capital increased from Dec. 2021 (₪61.28 Mil) to Dec. 2022 (₪77.49 Mil) and increased from Dec. 2022 (₪77.49 Mil) to Dec. 2023 (₪86.24 Mil).


Pharmocann Global Additional Paid-In Capital Historical Data

The historical data trend for Pharmocann Global's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global Additional Paid-In Capital Chart

Pharmocann Global Annual Data
Trend Dec09 Dec10 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.32 58.32 61.28 77.49 86.24

Pharmocann Global Quarterly Data
Dec17 Jun18 Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.57 77.49 77.49 80.03 86.24

Pharmocann Global Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Pharmocann Global Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmocann Global (XTAE:PMCN-M) Business Description

Traded in Other Exchanges
N/A
Address
Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201
Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines